The significance of the p73 gene, a homologue of the p53 gene, in esophageal cancers is not fully understood. In order to clarify the role of p73 expression in esophageal cancers, p73 expression was immunohistochemically investigated in 106 surgically resected esophageal cancers and the results were compared with various clinicopathological factors. In normal esophageal epithelium, the expression of p73 was observed only in the nuclei of basal cells. In esophageal cancers, p73 immunoreactivity was observed in all intraepithelial lesions except one cancer, and was reduced with cancer invasion, to 78% and 64% at superficial invasion and deep invasion sites, respectively. However, p73 expression was not correlated with any other clinicopathological factor. The expressions of p53 and p21 were also investigated in esophageal cancer. To evaluate the status of the p53 gene mutation immunohistochemically, two monoclonal antibodies (DO7 and PAb240) were used. There seemed to be an inverse correlation between p73 expression and p53 mutation. Moreover, the expression of p21 was highly correlated with p73 expression irrespective of the p53 mutation status. In human esophageal cancers, p73 expression decreased with increasing degree of tumor invasion, and its decreased expression in local advanced tumor caused down-regulation of p21 expression, which might reflect tumor progression. (Cancer Sci 2003; 94: 612-617) sophageal cancers have relatively high mortality rates, despite recent progress in cancer diagnosis and treatment.1) In Japan, long-term follow-up data of a total 11 642 esophagectomized cases show that the prognosis still remains poor, with a mean 5-year survival rate of approximately 36%, even if the esophagectomy is curative.2) Moreover, lymph node metastasis frequently occurs in esophageal cancers compared with other gastrointestinal malignancies, resulting in a poor outcome even for esophageal cancer patients detected at an early stage. 3,4) About 40% of esophageal carcinomas with submucosal invasion have already metastasized to the lymph node, 3) and only 60% of esophageal cancer patients with submucosal invasion survive for 5 years.
2)Recent advances in molecular biology have elucidated that various oncogenes and tumor suppressor genes are closely related to the development and progression of esophageal carcinomas.5-11) Inactivation of the INK4a locus or p16 is the most frequent genetic abnormality in esophageal cancers and occurs in the majority of esophageal cancers at the early stage of carcinogenesis.12, 13) Loss or down-regulation of p16 expression in esophageal cancers is attributed to genetic changes such as homozygous deletion or point mutation in addition to epigenetic hypermethylation of the gene.11) Amplification of the cyclin D1 gene is also a well-known genetic change in esophageal cancers and its overexpression is closely related with the invasiveness of cancer cells and the patient's outcome. 5,9) Furthermore, p53 gene mutation is detected in more than half of esophageal carcinomas and a large ...